BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37873581)

  • 1. Selective Inhibition of Hepatic Stellate Cell and Fibroblast-derived LOXL1 Attenuates BDL and Mdr2
    Yan X; Zhang N; Wei L; Zhang W; Huang T; Li W; Chen W; Yang A; You H
    Am J Physiol Gastrointest Liver Physiol; 2023 Oct; ():. PubMed ID: 37873581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
    Nishio T; Hu R; Koyama Y; Liang S; Rosenthal SB; Yamamoto G; Karin D; Baglieri J; Ma HY; Xu J; Liu X; Dhar D; Iwaisako K; Taura K; Brenner DA; Kisseleva T
    J Hepatol; 2019 Sep; 71(3):573-585. PubMed ID: 31071368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
    Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
    Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.
    Kyritsi K; Chen L; O'Brien A; Francis H; Hein TW; Venter J; Wu N; Ceci L; Zhou T; Zawieja D; Gashev AA; Meng F; Invernizzi P; Fabris L; Wu C; Skill NJ; Saxena R; Liangpunsakul S; Alpini G; Glaser SS
    Hepatology; 2020 Mar; 71(3):990-1008. PubMed ID: 31344280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism.
    Li J; Zhu X; Zhang M; Zhang Y; Ye S; Leng Y; Yang T; Kong L; Zhang H
    J Hepatol; 2021 Aug; 75(2):400-413. PubMed ID: 33746084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective depletion of hepatic stellate cells-specific LOXL1 alleviates liver fibrosis.
    Yang A; Yan X; Xu H; Fan X; Zhang M; Huang T; Li W; Chen W; Jia J; You H
    FASEB J; 2021 Oct; 35(10):e21918. PubMed ID: 34569648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
    McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
    Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
    Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J
    Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis.
    Chen L; Zhou T; White T; O'Brien A; Chakraborty S; Liangpunsakul S; Yang Z; Kennedy L; Saxena R; Wu C; Meng F; Huang Q; Francis H; Alpini G; Glaser S
    Hepatology; 2021 Jun; 73(6):2411-2428. PubMed ID: 32964473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice.
    Yang A; Yan X; Fan X; Shi Y; Huang T; Li W; Chen W; Jia J; You H
    Hepatol Int; 2021 Oct; 15(5):1122-1135. PubMed ID: 34014450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries.
    Beaussier M; Wendum D; Schiffer E; Dumont S; Rey C; Lienhart A; Housset C
    Lab Invest; 2007 Mar; 87(3):292-303. PubMed ID: 17260005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
    Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
    Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
    Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
    Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
    Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
    Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
    Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
    [No Abstract]   [Full Text] [Related]  

  • 16. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
    Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
    Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.
    Zhang J; Lyu Z; Li B; You Z; Cui N; Li Y; Li Y; Huang B; Chen R; Chen Y; Peng Y; Fang J; Wang Q; Miao Q; Tang R; Gershwin ME; Lian M; Xiao X; Ma X
    Hepatology; 2023 Jul; 78(1):10-25. PubMed ID: 36799463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
    Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
    J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the
    Fuchs CD; Sroda N; Scharnagl H; Gupta R; Minto W; Stojakovic T; Liles JT; Budas G; Hollenback D; Trauner M
    JHEP Rep; 2023 Nov; 5(11):100874. PubMed ID: 37841639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes.
    Wan Y; Ceci L; Wu N; Zhou T; Chen L; Venter J; Francis H; Bernuzzi F; Invernizzi P; Kyritsi K; Baker P; Huang Q; Wu C; Sybenga A; Alpini G; Meng F; Glaser S
    Lab Invest; 2019 Jun; 99(6):764-776. PubMed ID: 30700848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.